November 27, 2024 LONDON – Visioneering Technologies, Inc. was presented with The Contact Lens Award of 2024 by The Optician Awards in...
ATLANTA — Visioneering Technologies, Inc. (ASX: VTI), a medical device company and producer of the NaturalVue Multifocal 1 Day Contact Lenses, announced...
July 13, 2022 ATLANTA – Medical device company and producer of NaturalVue Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc (ASX:VTI) announced...
February 17, 2021 ATLANTA – Visioneering Technologies, Inc. (VTI) has received investment commitments of $22 million, according to a company announcement. Capital...
July 14, 2020 Visioneering Technologies is launching a new website as part of a rebranding campaign aimed at sharpening its connection with...
May 18, 2020 Atlanta, Georgia – U.S.-based medical device company, Visioneering Technologies Inc. recently shared its new MyChild & Myopia education materials...
Together, we know more and can accomplish more.
The agreement heralds the next step in Visioneering's accelerating global expansion.
Tens of millions of myopic children around the world need our help.
Jobson Medical Information will be the official North American media sponsor.
Jobson Optical Research, sponsored by Essilor, polled more than 300 optometrists in the U.S.
Myopia may be pervasive, but so are efforts to spread awareness and inform ways to reduce progression. Resources abound.